Phase II study of spirogermanium in advanced adenocarcinoma of the prostate: a Southwest Oncology Group Study.
Veteran's Administration Medical Center, Albuquerque, NM.
J H
JH
Saiers
B
B
Blumenstein
M
M
Slavik
J H
JH
Costanzi
E D
ED
Crawford
D000230:Adenocarcinoma / Q000188:drug therapy*; D004341:Drug Evaluation; D006801:Humans; D008297:Male; D009942:Organometallic Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013141:Spiro Compounds / Q000009:adverse effects / Q000627:therapeutic use*
D009942:Organometallic Compounds; D013141:Spiro Compounds; C026818:spirogermanium